In this work simultaneous T1 and T2 mapping via MR Fingerprinting was used to observe the distribution of dysprosium and gadolinium MRI contrast agents in a mouse tumor model. Changes from baseline in T1 and T2 were observed using each agent alone and an increased effect was seen when agents were used in combination. Additionally, a decrease in the dysprosium dose lead to a reduction in the level of T1 and T2 enhancement observed. These results indicate that MRF might be able to be used to track multiple MRI contrast agents in vivo.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords